• Exchange: -
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Amarantus Bioscience Holdings Inc

091:GR

Ticker Delisted

Snapshot for Amarantus Bioscience Holdings Inc (091)

Open: - Day's Range: - Volume: 0
Previous Close: - 52wk Range: - 1-Yr Rtn: -

Stock Chart for 091

No chart data available.
  • 091:GR
  • 1M
  • 1Y
0.000
Interactive 091 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 091

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. DAX -
Earnings Per Share (ttm) -
Est. EPS -
Est. PEG Ratio -
Market Cap (M EUR) 0.00
Shares Outstanding (M) 0.00
30 Day Average Volume -
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/19/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 091

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for 091

Amarantus Bioscience Holdings, Inc. is a biotechnology holding company. The Company, through its subsidiaries, certain biologics surrounding the intellectual property and proprietary technologies it owns to treat and/or diagnose Parkinson's disease, traumatic brain Injury, Ischemic heart disease and other human diseases.

Gerald E CommissiongPresident/CEO/COORobert FarrellChief Financial Officer
John W CommissiongChief Scientific Ofcr/Co-FounderMarc E FaerberVP:Financial Ops/Treasurer
More Company Profile & Key Executives for 091

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil